IP-82, an anti-inflammatory agent derived from Ibunac was given to a total of 49 patients who manifested acute or chronic inflammation at the pharynx-laryx region.
A high curative effect of this drug was shown as a statistical analysis proved a significant difference from placebo group with p<0.005 in X2 test.
This drug was found to have a potent effect particulary against pains due to acute inflamma-tory process in the throat.
